These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 31606714)

  • 21. Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma.
    Pan ZQ; Zhang SJ; Wang XL; Jiao YX; Qiu JJ
    Behav Neurol; 2020; 2020():1712604. PubMed ID: 33163122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas.
    Yang G; Sha Y; Wang X; Tan Y; Zhang H
    Contrast Media Mol Imaging; 2022; 2022():8952357. PubMed ID: 35386727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Ai Y; Zhu X; Zhang Y; Li W; Li H; Zhao Z; Zhang J; Ning B; Li C; Zheng Q; Zhang J; Jin J; Li Y; Xie C; Jin X
    Radiother Oncol; 2024 Aug; 197():110328. PubMed ID: 38761884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automatic image segmentation and online survival prediction model of medulloblastoma based on machine learning.
    Zhou L; Ji Q; Peng H; Chen F; Zheng Y; Jiao Z; Gong J; Li W
    Eur Radiol; 2024 Jun; 34(6):3644-3655. PubMed ID: 37994966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas.
    Huo X; Wang Y; Ma S; Zhu S; Wang K; Ji Q; Chen F; Wang L; Wu Z; Li W
    Medicine (Baltimore); 2023 Dec; 102(51):e36581. PubMed ID: 38134061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Deep Learning-Based Radiomics Model for Prediction of Survival in Glioblastoma Multiforme.
    Lao J; Chen Y; Li ZC; Li Q; Zhang J; Liu J; Zhai G
    Sci Rep; 2017 Sep; 7(1):10353. PubMed ID: 28871110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
    Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
    Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-based intratumoral and peritumoral radiomics for preoperative prediction of glioma grade: a multicenter study.
    Tan R; Sui C; Wang C; Zhu T
    Front Oncol; 2024; 14():1401977. PubMed ID: 38803534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
    Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
    J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of signal intensity normalization of MRI on the generalizability of radiomic-based prediction of molecular glioma subtypes.
    Foltyn-Dumitru M; Schell M; Rastogi A; Sahm F; Kessler T; Wick W; Bendszus M; Brugnara G; Vollmuth P
    Eur Radiol; 2024 Apr; 34(4):2782-2790. PubMed ID: 37672053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y; Xie Z; Zang Y; Zhang S; Gu D; Zhou M; Gevaert O; Wei J; Li C; Chen H; Du J; Liu Z; Dong D; Tian J; Zhou D
    J Neurooncol; 2018 Nov; 140(2):297-306. PubMed ID: 30097822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomic signature of
    Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
    Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
    Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
    Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
    Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
    Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma.
    Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y
    Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.
    Zhao S; Su Y; Duan J; Qiu Q; Ge X; Wang A; Yin Y
    J Bone Oncol; 2019 Dec; 19():100263. PubMed ID: 31667064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.
    Lu J; Li X; Li H
    Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.